The US Bankruptcy Court granted an order for the extension of the exclusivity periods for MabVax Therapeutics Holdings, Inc. on July 29, 2019. As per the order, the debtor’s exclusivity period to file its plan and to solicit votes on its plan, have been extended by 120 days i.e. up to November 18, 2019 and January 17, 2020, respectively.